Capital Region Cancer Research to Sponsor Precision Medicine Symposium on June 11
FOR IMMEDIATE RELEASE
ALBANY, NEW YORK – The Capital Region Cancer Research group (CRCR) on June 11 will sponsor a symposium as part of their CRCR New Frontiers Series, entitled “Precision Medicine in Cancer Treatment and Prevention.” This virtual event will be held from 9 a.m. to 2:30 p.m. and will be the seventh such cancer symposium in this series.
The symposium will feature leading cancer research experts, cutting-edge medical oncologists, community-based cancer patient organizations, and selected presentations from graduate student and post-doc trainees. The symposium is intended to bring together investigators in New York’s Capital Region who work on various aspects of cancer
“Precision medicine is transforming the medical treatment landscape including cancer care. This approach takes advantage of cutting-edge technologies and diagnostics that identify and target molecular nuances to ultimately tailor therapies to individual patients. These technologies include many that will be presented as part of this symposium including theranostics, cytokine-directed therapy, Fluorescent Lifetime FRET imaging, single-cell transcriptomic profiling, and even artificial intelligence as well as the patient-based MYLUNG initiative to improve understanding of molecular testing challenges to improve lung cancer patient care. These and other new strategies promise to play a major role in contributing to the ultimate goal of the CRCR and our attending community organizations – the cure of cancer,” said Dana R. Crawford, Ph.D., Associate Professor at Albany Medical College and Chair of the CRCR.
The CRCR is an inter-institutional organization that was created in the Capital Region in the summer of 2006. The purpose of the group is to promote cancer research interactions among different Albany area facilities and personnel. Member organizations include Wadsworth Center, SUNY-Albany, Albany Medical Center (AMC), General Electric (GE), Rensselaer Polytechnic Institute (RPI), SUNY Polytechnic Institute, Albany College of Pharmacy (ACPHS/PRI), Stratton VA Medical Center, Taconic Biosciences, Inc., and New York Oncology Hematology (NYOH).
“The Capital Region Cancer Research group’s work is vitally important, and the New Frontiers Symposium is certain to feature a wealth of information on new cancer research. The Center for Economic Growth is proud to support the CRCR and this event as well as help connect members of the biotechnology industry working on this important research.” said Katie Newcombe, Chief Economic Development Officer of the Center for Economic Growth.
Registration is now open and more information on the event can be found here.
The Center for Economic Growth (CEG) is dedicated to driving economic growth in New York’s eight-county, 1.1-million-person Capital Region. As the nonprofit regional economic development organization, we do this by attracting investment and talent; growing manufacturing and workforce capabilities, leveraging industry clusters, and developing the entrepreneurial ecosystem. We serve as a catalyst and work with partners and stakeholders to prepare the region to compete and move high-impact strategies and projects forward. An affiliate of the Capital Region Chamber, CEG is supported by investors in business, government, education, and the nonprofit sectors who are committed to sustainable economic growth and shared prosperity. For more information on CEG, visit www.ceg.org.